SPARK | REACH Seminar Series
Jason Ruth, Ph.D. joined 5AM Ventures as an Associate in 2017 and was recently promoted to Senior Associate. He serves as an Observer on the Boards of Homology Medicines (NASDAQ: FIXX), Expansion Therapeutics, and Entrada Therapeutics.
• Chief Scientific Officer and as a Scientific Advisory Board member for the Castleman Disease Collaborative Network
• Received his Ph.D. in Bioengineering fromthe University of Pennsylvania
Wednesday, February 19
5 - 7 pm
Location: Skaggs School of Pharmacy, room v20-1000